AstraZeneca's tozorakimab targets interleukin-33, a protein released by damaged cells that drives airway inflammation and mucus production in chronic obstructive pulmonary disease

552c7ae14Space

Health

Health news, debates, and claims covering public health, mental health, nutrition, medical care, and health policy.

1 debate·6,984 claims·43 news stories

0